• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Anthogyr AXIOM IMPLANT ?3.4 x 10.0; Endosseous Dental Implant

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Anthogyr AXIOM IMPLANT ?3.4 x 10.0; Endosseous Dental Implant Back to Search Results
Catalog Number OP34100
Medical Device Problem Code Loss of Osseointegration (2408)
Health Effect - Clinical Codes Unspecified Infection (1930); Pain (1994); Fibrosis (3167); Swelling/ Edema (4577)
Date of Event 05/27/2026
Type of Reportable Event Serious Injury
Event or Problem Description
The clinician reports the implant was inserted (b)(6) 2025 in fdi 13.On (b)(6) 2026, loss of osseointegration was verified.The device was forwarded to the manufacturer.At the event the patient experienced: peri-implantitis, pain, mobility and swelling.No further patient complications were reported.
 
Additional Manufacturer Narrative
The batch number could be verified.Our manufacturing q-system assures, that production and process controls are in place to ensure that batches confirm to the applicable specifications before they are distributed.? the loss of an endosseous dental implant after successful osseointegration and restoration is a known inherent risk of the procedure.Implants may have to be removed in case one or more of the implant success criteria are not met.Implant success criteria according to buser et al.(1991) are: 1.Absence of persistent subjective complaints such as pain, foreign body sensation and /or dysesthesia.2.Absence of a recurrent peri-implant infection with suppuration.3.Absence of implant mobility.4.Absence of a continuous radiolucency around the implant.The manufacturer's trend analysis confirms that the reported failure rate associated with its dental implants is below the expected failure rate for this treatment as published in the scientific literature.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIOM IMPLANT ?3.4 x 10.0
Common Device Name
Endosseous Dental Implant
Manufacturer (Section D)
Anthogyr
2237, avenue andr?-lasquin
sallanches 74700
FR  74700
Manufacturer (Section G)
Anthogyr
2237, avenue andr?-lasquin
sallanches 74700
FR   74700
Manufacturer Contact
jennifer jackson
60 minuteman road
andover, MA 01810
+1(978)747-2509
MDR Report Key50413931
Report Number0008020776-2026-000936
Device Sequence Number18418868
Product Code DZE
UDI-Device Identifier03663394000062
UDI-Public03663394000062
Combination Product (Y/N)N
Initial Reporter CountryRS
PMA/510(K) Number
K101913
Summary Report (Y/N)N
Device Implanted Year2025
Device Explanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Dentist
Type of Report Initial
Report Date (Section B) 08/24/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/16/2026
Device Catalogue NumberOP34100
Device Lot Number21-476600
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer07/30/2026
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Event Location Other
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date08/24/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/16/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age46 YR
Patient SexMale
-
-